Jennifer Cunningham

Statistics

Publications

Citations

4.3K

H-Index

Active since

2017

Affiliations

National Institute of Allergy and Infectious Diseases(Current)

National Institutes of Health

Population Health Research Institute

McMaster University

Sunnybrook Health Science Centre

Jennifer Cunningham is an author at National Institute of Allergy and Infectious Diseases specializing in infectious diseases, vaccinology, and vaccination.

ORCID

Publications per year

2017–2024

Publications

Compassionate Use of Remdesivir for Patients with Severe Covid-19

Jonathan Grein, Norio Ohmagari, Daniel D. Shin et al. · New England Journal of Medicine · 2020 · 2.9K citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +12

A proof of concept for structure-based vaccine design targeting RSV in humans

Michelle C. Crank, Tracy J. Ruckwardt, Kaitlyn M. Morabito et al. · Science · 2019 · 340 citations

Life Sciences, Immunology, Infectious Diseases +16

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

Martin R. Gaudinski, Katherine V. Houser, Kaitlyn M. Morabito et al. · The Lancet · 2017 · 304 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial

Katherine V. Houser, Grace Chen, Cristina Carter et al. · Nature Medicine · 2022 · 163 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study

Martin R. Gaudinski, Emily E. Coates, Laura Novik et al. · The Lancet · 2019 · 128 citations · Full text

Pharmacy, Infectious Diseases, Pharmacokinetics +14

1–5 of 14